GL392
GL392 is a senolytic agent that selectively delivers the potent senolytic compound Dasatinib (HY-10181) to senescent cells. GL392 targets lipofuscin in senescent cells via the LBD domain and is linked to Dasatinib through an ester bond. Upon internalization in senescent cells, Dasatinib is released, inducing apoptosis of the senescent cells. Additionally, GL392 is encapsulated in PEO-b-PCL micelles to ensure effective intracellular delivery and minimize systemic toxicity. GL392 can be used in cancer research applications [1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Related Pathways
Apoptosis
Field of Research
Cancer
Smiles
CC1(COC(CCC(OCCN2CCN(C3=CC(NC4=NC=C(C(NC5=C(C)C=CC=C5Cl)=O)S4)=NC(C)=N3)CC2)=O)=O)NC6=CC=CC(C6=C(N1)C=C7)=C7/N=N/C(C=C8)=C9C(C=CC=C9)=C8/N=N/C%10=CC=CC=C%10
Molecular Formula
C55H52ClN13O5S
Molecular Weight
1042.60
References & Citations
[1]Magkouta S, et al. Generation of a selective senolytic platform using a micelle-encapsulated Sudan Black B conjugated analog. Nat Aging. 2025 Jan;5 (1) :162-175. doi: 10.1038/s43587-024-00747-4. Epub 2024 Dec 27. Erratum in: Nat Aging. 2025 Jan 31.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15332689 1 Vial
Lentiviral human CLCNKA shRNA (UAS) - Lentiviral human CLCNKA shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 
T5600-10F-AP 200 µL
Tissue Plasminogen Activator (tPA) (AP) discontinued
Sign In for Pricing
View Details 